The long-standing debate regarding caffeine consumption and its impact on nocturnal rest has primarily centered on a singular, observable metric:…
Read More
Gilead Executive Sounds Alarm on Limited Innovation Investment Hindering Access to Advanced Therapies
The Netherlands faces significant challenges in ensuring timely patient access to life-changing advanced therapy medicinal products (ATMPs), a situation exacerbated…
Read More
